Institutional investors purchased a net $1.5 million shares of TRNX during the quarter ended December 2012, and now own 32.65% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
| Individual stakeholders | 56.19% |
| Other institutional | 16.84% |
| Mutual fund holders | 15.81% |